Cochlear, the global leader in implantable hearing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved the Nucleus((R) )5 System for adults and children with severe-to-profound hearing loss.
More: continued here
FDA approves Cochlear’s Nucleus 5 System
September 9, 2009 | 0 comments
